Sipatrigine
Based on 1 publication(s) in Google Scholar
Sipatrigine (619C89), a neuroprotective agent, is a glutamate release inhibitor, voltage-dependent sodium channel and calcium channel inhibitor, penetrating the central nervous system. Has the potential in the study for focal cerebral ischemia and stroke.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.63%
- CAS No.: 130800-90-7
- Formule: C15H16Cl3N5
- Masse moléculaire:372.68
-
Stockage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-B0211
RiluzoleAnticonvulsant Agent -
HY-B0246
CarbamazepineAnticonvulsant -
HY-B0211R
Riluzole (Standard)Anticonvulsant Agent -
HY-B0495
LamotrigineAnticonvulsant Agent -
HY-B0246R
Carbamazepine (Standard)Anticonvulsant -
HY-12283
RostafuroxinATP1A1 Antognist -
HY-15529
S0859Na+/HCO3- Cotransporter Inhibitor -
HY-B0495R
Lamotrigine (Standard)Anticonvulsant Agent -
HY-B0285B
Amiloride hydrochloride dihydrateENaC/uTPA Inhibitor -
HY-B0387
Ibutilide fumarateAnti-arrhythmic Agent -
HY-N6691
VeratridineVGSCs Agonist -
HY-B0448
PhenytoinVirus Protease Inhibitor
Publications Citing Use of MedChemExpress (MCE) Sipatrigine
MoreVoir tous les produits spécifiques à Isoform Calcium Channel
More
Activité biologique
Description
IC50 & Target
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | IC50 |
2.55 μM
Compound: 1 (BW-619C89)
|
Blockade of synaptosomal sodium channels, inhibition of [14C]guanidinium ion flux into CHO cells expressing Type II sodium channel
Blockade of synaptosomal sodium channels, inhibition of [14C]guanidinium ion flux into CHO cells expressing Type II sodium channel
|
10.1016/0960-894X(95)00392-7 |
| HEK293 | IC50 |
4 μM
Compound: 19
|
Inhibition of of human TREK1 expressed in HEK293 cells assessed as reversible current depression
Inhibition of of human TREK1 expressed in HEK293 cells assessed as reversible current depression
|
[PMID: 26588045] |
Chemical Information
-
CAS No. 130800-90-7
-
Appearance Solid
-
Masse moléculaire 372.68
-
Formule C15H16Cl3N5
-
Color Off-white to gray
-
SMILES
NC1=NC(N2CCN(C)CC2)=NC=C1C3=CC(Cl)=CC(Cl)=C3Cl
-
Synonyms
619C89; BW 619C89
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Anal Chem
Exposome-Scale Investigation of Cl-/Br-Containing Chemicals Using High-Resolution Mass Spectrometry, Multistage Machine Learning, and Cloud Computing. [Abstract]2025 Jun 3;97(21):11099-11109. PMID: 40401576
Solvant et solubilité
In Vitro:
DMSO : 50 mg/mL (134.16 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (5.58 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (5.58 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureté et documentation
-
Fiche technique (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6833 mL | 13.4163 mL | 26.8327 mL | 67.0817 mL |
| 5 mM | 0.5367 mL | 2.6833 mL | 5.3665 mL | 13.4163 mL | |
| 10 mM | 0.2683 mL | 1.3416 mL | 2.6833 mL | 6.7082 mL | |
| 15 mM | 0.1789 mL | 0.8944 mL | 1.7888 mL | 4.4721 mL | |
| 20 mM | 0.1342 mL | 0.6708 mL | 1.3416 mL | 3.3541 mL | |
| 25 mM | 0.1073 mL | 0.5367 mL | 1.0733 mL | 2.6833 mL | |
| 30 mM | 0.0894 mL | 0.4472 mL | 0.8944 mL | 2.2361 mL | |
| 40 mM | 0.0671 mL | 0.3354 mL | 0.6708 mL | 1.6770 mL | |
| 50 mM | 0.0537 mL | 0.2683 mL | 0.5367 mL | 1.3416 mL | |
| 60 mM | 0.0447 mL | 0.2236 mL | 0.4472 mL | 1.1180 mL | |
| 80 mM | 0.0335 mL | 0.1677 mL | 0.3354 mL | 0.8385 mL | |
| 100 mM | 0.0268 mL | 0.1342 mL | 0.2683 mL | 0.6708 mL |
Sipatrigine Related Classifications
HY-108335 Related Classifications
Powered by Bioz